About
Ernst Geutjes is a Venture Partner at Aglaia Oncology Funds. Aglaia invests in oncology drug development companies and has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. The Aglaia team has decades of experience in cancer research and oncology drug development. Since 2004, Aglaia has built an excellent reputation in starting up biotech companies that focus on oncology drug development.
Sign up to see Ernst Geutjes's full profile
Access investment thesis, focus areas, bio, and contact details for Ernst Geutjes and 22,000+ other VC professionals.
Aglaia
Bilthoven, NL